Pages that link to "Q28366044"
Jump to navigation
Jump to search
The following pages link to In vitro susceptibility of varicella-zoster virus to acyclovir (Q28366044):
Displaying 50 items.
- Varicella-zoster virus (Q24683811) (← links)
- Use of an enzyme-linked immunosorbent assay performed directly on fixed infected cell monolayers for evaluating drugs against varicella-zoster virus (Q27478097) (← links)
- Antiviral drug resistance: mechanisms and clinical implications (Q28282376) (← links)
- 6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus (Q28321395) (← links)
- Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus (Q28327167) (← links)
- Phosphorylation of beta-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirus (Q28345180) (← links)
- Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus (Q28359820) (← links)
- Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate (Q28359883) (← links)
- Acyclic guanosine analogs as inhibitors of human cytomegalovirus (Q28360560) (← links)
- Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture (Q28361902) (← links)
- Inhibitory effects of antiherpesviral thymidine analogs against varicella-zoster virus (Q28366145) (← links)
- In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds (Q28366155) (← links)
- Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes (Q28379207) (← links)
- Inhibition of Human Cytomegalovirus DNA Maturation by a Benzimidazole Ribonucleoside Is Mediated through the UL89 Gene Product (Q28379289) (← links)
- Tri-partite complex for axonal transport drug delivery achieves pharmacological effect (Q33525199) (← links)
- Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment (Q33585362) (← links)
- Antiviral selection in the management of acute retinal necrosis. (Q33644146) (← links)
- Valacyclovir and acyclovir pharmacokinetics in immunocompromised children (Q33776931) (← links)
- 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir (Q33836051) (← links)
- Acyclovir: discovery, mechanism of action, and selectivity (Q34345105) (← links)
- Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy (Q34500573) (← links)
- Oral acyclovir for herpes zoster ophthalmicus (Q34545573) (← links)
- Oral acyclovir in the treatment of acute herpes zoster ophthalmicus (Q34688940) (← links)
- Pharmacokinetics and safety of multiple-dose valaciclovir in geriatric volunteers with and without concomitant diuretic therapy. (Q35121549) (← links)
- Acyclovir: A Decade Later (Q35186637) (← links)
- Acyclovir treatment of experimental simian varicella infection of monkeys (Q35671376) (← links)
- Uptake, distribution, and anabolism of acyclovir in herpes simplex virus-infected mice (Q35673064) (← links)
- Effect of acyclovir and interferon on human hematopoietic progenitor cells (Q35673321) (← links)
- Effect of several antiviral agents on human lymphocyte functions and marrow progenitor cell proliferation (Q35740490) (← links)
- Susceptibility of vaccine strains of varicella-zoster virus to antiviral compounds (Q35758745) (← links)
- Antiviral therapy: current concepts and practices (Q36070394) (← links)
- 6-Deoxyacyclovir: a xanthine oxidase-activated prodrug of acyclovir (Q36261735) (← links)
- Valacyclovir as Initial Treatment for Acute Retinal Necrosis: A Pharmacokinetic Modeling and Simulation Study. (Q38867550) (← links)
- Varicella-zoster virus infection and immunization in the healthy and the immunocompromised host (Q39188767) (← links)
- The future of antiviral chemotherapy (Q39563538) (← links)
- Cytotoxic agents for use in dermatology. I. (Q39822812) (← links)
- Metabolism and pharmacokinetics of the anti-varicella-zoster virus agent 6-dimethylaminopurine arabinoside (Q39867911) (← links)
- Advances in Antiviral Therapy: Acydovir (Q40079186) (← links)
- Acyclovir: New era in antiviral chemotherapy (Q40081290) (← links)
- 6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virus (Q40086870) (← links)
- Selective anabolism of 6-methoxypurine arabinoside in varicella-zoster virus-infected cells (Q40087739) (← links)
- Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment (Q40115283) (← links)
- The Clinical use of Intravenous Acyclovir (Q40137159) (← links)
- Acyclovir A Review of its Pharmacodynamic Properties and Therapeutic Efficacy (Q40138670) (← links)
- Chickenpox Virus (Q40139628) (← links)
- Antiherpes drugs: Promises and pitfalls (Q40142222) (← links)
- Virus drug-resistance: mechanisms and consequences (Q40143508) (← links)
- Clinical pharmacokinetics of acyclovir (Q40149131) (← links)
- The clinical pharmacology of acyclovir (Q40153863) (← links)
- The mechanism of action, pharmacokinetics and toxicity of acyclovir — A review (Q40155980) (← links)